News
The trial drug Trontinemab is designed to bypass the blood brain barrier, delivering more treatment directly to the brain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback